Literature DB >> 25818239

Total cholesterol performance of Abell-Levy-Brodie-Kendall reference measurement procedure: Certification of Japanese in-vitro diagnostic assay manufacturers through CDC's Cholesterol Reference Method Laboratory Network.

Masakazu Nakamura1, Hiroyasu Iso2, Akihiko Kitamura2, Hironori Imano2, Masahiko Kiyama3, Shinji Yokoyama4, Yuzo Kayamori5, Isao Koyama6, Kunihiro Nishimura7, Michikazu Nakai7, Mahnaz Dasti8, Hubert W Vesper8, Tamio Teramoto9, Yoshihiro Miyamoto10.   

Abstract

BACKGROUND: Accurate measurement of total cholesterol (TC) is important for cardiovascular disease risk management. The US Centers for Disease Control and Prevention (CDC) and Cholesterol Reference Method Laboratory Network (CRMLN) perform Abell-Levy-Brodie-Kendall (AK) reference measurement procedure (RMP) for TC as a secondary reference method, and implement Certification Protocol for Manufacturers. Japanese CRMLN laboratory at Osaka performed the AK RMP for 22 years, and conducted TC certification for reagent/calibrator/instrument systems of six Japanese manufacturers every 2 years for 16 years. Osaka TC performance was examined and compared to CDC's reference values.
METHODS: AK RMP involved sample hydrolysis, cholesterol extraction, and determination of cholesterol levels by spectrophotometry. The Certification Protocol for Manufacturers includes comparison with AK RMP using at least 40 fresh specimens. Demonstration of average bias ≤3% and total coefficient of variation ≤3% qualified an analytical system for certification.
RESULTS: In the AK RMP used in the Osaka CRMLN laboratory, the regression equation for measuring TC was y (Osaka)=1.000x (CDC)+0.032 (n=619, R(2)=1.000). Six Japanese manufacturers had allowable performance for certification.
CONCLUSIONS: The AK RMP for TC measurement was accurate, precise, and stable for 22 years. Six Japanese manufacturers were certified for 16 years.
Copyright © 2015 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  AK RMP; CDC; CRMLN; Certification; TC

Mesh:

Substances:

Year:  2015        PMID: 25818239      PMCID: PMC4579524          DOI: 10.1016/j.cca.2015.03.026

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN: 0009-8981            Impact factor:   3.786


  24 in total

1.  Current status of blood cholesterol measurement in clinical laboratories in the United States: a report from the Laboratory Standardization Panel of the National Cholesterol Education Program.

Authors: 
Journal:  Clin Chem       Date:  1988-01       Impact factor: 8.327

2.  Enzymatic determination of total serum cholesterol.

Authors:  C C Allain; L S Poon; C S Chan; W Richmond; P C Fu
Journal:  Clin Chem       Date:  1974-04       Impact factor: 8.327

3.  Preparation and properties of a cholesterol oxidase from Nocardia sp. and its application to the enzymatic assay of total cholesterol in serum.

Authors:  W Richmond
Journal:  Clin Chem       Date:  1973-12       Impact factor: 8.327

4.  Statistical methods for assessing agreement between two methods of clinical measurement.

Authors:  J M Bland; D G Altman
Journal:  Lancet       Date:  1986-02-08       Impact factor: 79.321

Review 5.  Standardization of lipid, lipoprotein, and apolipoprotein measurements.

Authors:  G R Cooper; G L Myers; S J Smith; E J Sampson
Journal:  Clin Chem       Date:  1988       Impact factor: 8.327

Review 6.  The Centers for Disease Control-National Heart, Lung and Blood Institute Lipid Standardization Program. An approach to accurate and precise lipid measurements.

Authors:  G L Myers; G R Cooper; C L Winn; S J Smith
Journal:  Clin Lab Med       Date:  1989-03       Impact factor: 1.935

7.  Isotope dilution/mass spectrometry of serum cholesterol with [3,4-13C]cholesterol: proposed definitive method.

Authors:  O Pelletier; L A Wright; W C Breckenridge
Journal:  Clin Chem       Date:  1987-08       Impact factor: 8.327

8.  The Lipid Research Clinics Coronary Primary Prevention Trial results. I. Reduction in incidence of coronary heart disease.

Authors: 
Journal:  JAMA       Date:  1984-01-20       Impact factor: 56.272

9.  Report of the National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. The Expert Panel.

Authors: 
Journal:  Arch Intern Med       Date:  1988-01

10.  Interlaboratory testing of the transferability of a candidate reference method for total cholesterol in serum.

Authors:  G R Cooper; S J Smith; I W Duncan; A Mather; W D Fellows; T Foley; I D Frantz; J B Gill; T A Grooms; I Hynie
Journal:  Clin Chem       Date:  1986-06       Impact factor: 8.327

View more
  4 in total

1.  Evaluation of the value of conventional and unconventional lipid parameters for predicting the risk of diabetes in a non-diabetic population.

Authors:  Guotai Sheng; Maobin Kuang; Ruijuan Yang; Yanjia Zhong; Shuhua Zhang; Yang Zou
Journal:  J Transl Med       Date:  2022-06-11       Impact factor: 8.440

2.  Leukocyte Count and Risks of Stroke and Coronary Heart Disease: The Circulatory Risk in Communities Study (CIRCS).

Authors:  Jiaqi Li; Hironori Imano; Kazumasa Yamagishi; Mari Tanaka; Renzhe Cui; Isao Muraki; Mitsumasa Umesawa; Mina Hayama-Terada; Tetsuya Ohira; Masahiko Kiyama; Takeo Okada; Tomoko Sankai; Takeshi Tanigawa; Akihiko Kitamura; Hiroyasu Iso
Journal:  J Atheroscler Thromb       Date:  2021-03-21       Impact factor: 4.394

3.  Comparison of the Japan Society of Clinical Chemistry reference method and CDC method for HDL and LDL cholesterol measurements using fresh sera.

Authors:  Yuzo Kayamori; Masakazu Nakamura; Koji Kishi; Takashi Miida; Kunihiro Nishimura; Tomonori Okamura; Satoshi Hirayama; Hirotoshi Ohmura; Hiroshi Yoshida; Masumi Ai; Akira Tanaka; Hiroyuki Sumino; Masami Murakami; Ikuo Inoue; Tamio Teramoto; Shinji Yokoyama
Journal:  Pract Lab Med       Date:  2021-04-23

4.  Impact of Major Cardiovascular Risk Factors on the Incidence of Cardiovascular Disease among Overweight and Non-Overweight Individuals: The Circulatory Risk in Communities Study (CIRCS).

Authors:  Takumi Matsumura; Tomoko Sankai; Kazumasa Yamagishi; Yasuhiko Kubota; Mina Hayama-Terada; Isao Muraki; Mitsumasa Umesawa; Renzhe Cui; Hironori Imano; Tetsuya Ohira; Akihiko Kitamura; Takeo Okada; Masahiko Kiyama; Hiroyasu Iso
Journal:  J Atheroscler Thromb       Date:  2021-03-16       Impact factor: 4.928

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.